Inventor · disambiguated record
Wayne R. Gombotz
Also filed as: GOMBOTZ WAYNE · GOMBOTZ WAYNE R · GOMBOTZ WAYNE RICHARD
22 granted patents·9 pending applications·1,567 citations·filing 1989–2023
97Inventor score
Top patents by PatentIndex Score
31 records- 0198US7648702B2Stable aqueous formulation of a soluble TNF receptor and arginineIMMUNEX CORP·Filed 2007·Granted Jan 19, 2010·123 cites·26 claims
- 0298US5019400AVery low temperature casting of controlled release microspheresENZYTECH INC·Filed 1989·Granted May 28, 1991·710 cites·18 claims
- 0396US9475885B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2015·Granted Oct 25, 2016·15 cites·31 claims
- 0495US5942253AProlonged release of GM-CSFIMMUNEX CORP·Filed 1995·Granted Aug 24, 1999·158 cites·27 claims
- 0592US8119604B2Polypeptide formulationGOMBOTZ WAYNE R·Filed 2009·Granted Feb 21, 2012·20 cites·20 claims
- 0692US6274175B1Prolonged release of GM-CSFIMMUNEX CORP·Filed 1999·Granted Aug 14, 2001·101 cites·24 claims
- 0791US9011860B2Compositions for inhibiting MASP-2 dependent complement activationDUDLER THOMAS·Filed 2012·Granted Apr 21, 2015·20 cites·24 claims
- 0891US6569458B1Process for producing small particles of biologically active moleculesALKERMES INC·Filed 1993·Granted May 27, 2003·130 cites·10 claims
- 0990US9518111B2Compositions comprising a p75 tumor necrosis factor receptor/Ig fusion proteinIMMUNEX CORP·Filed 2014·Granted Dec 13, 2016·8 cites·23 claims
- 1089US6036978AControlled release polypeptide compositions and methods of treating inflammatory bowel diseaseIMMUNEX CORP·Filed 1996·Granted Mar 14, 2000·141 cites·1 claims
- 1185US8828947B2Polypeptide formulationGOMBOTZ WAYNE RICHARD·Filed 2012·Granted Sep 9, 2014·7 cites·23 claims
- 1283US2024092938A1Compositions for inhibiting masp-2 dependent complement activationOMEROS CORP·Filed 2023·Application pending·0 cites
- 1382US5451411AMethods and compositions for the oral delivery of therapeutic agentsUNIV WASHINGTON·Filed 1993·Granted Sep 19, 1995·52 cites·10 claims
- 1481US8790696B2Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological proceduresDEMOPULOS GREGORY A·Filed 2006·Granted Jul 29, 2014·2 cites·18 claims
- 1580US9295685B2Mixed micellesGOMBOTZ WAYNE R·Filed 2012·Granted Mar 29, 2016·4 cites·21 claims
- 1678US11104714B2Compositions comprising a P75 tumor necrosis factor receptor/Ig fusion proteinIMMUNEX CORP·Filed 2019·Granted Aug 31, 2021·0 cites·10 claims
- 1778US2022025016A1Compositions comprising a p75 tumor necrosis factor receptor/ig fusion proteinIMMUNEX CORP·Filed 2021·Application pending·0 cites
- 1877US5900238AVaccine delivery systemIMMUNEX CORP·Filed 1995·Granted May 4, 1999·56 cites·18 claims
- 1973US11613589B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2020·Granted Mar 28, 2023·0 cites·13 claims
- 2070US10683367B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2018·Granted Jun 16, 2020·0 cites·33 claims
- 2169US2019144523A1Compositions comprising a p75 tumor necrosis factor receptor/ig fusion proteinIMMUNEX CORP·Filed 2019·Application pending·0 cites
- 2267US2015031728A1Cyclooxygenase Inhibitor and Calcium Channel Antagonist Compositions and Methods for Use in Urological ProceduresOMEROS CORP·Filed 2014·Application pending·0 cites
- 2365US9855256B2Cyclooxygenase inhibitor and calcium channel antagonist compositions and methods for use in urological proceduresOMEROS CORP·Filed 2016·Granted Jan 2, 2018·0 cites·4 claims
- 2465US6120807AProlonged release of GM-CSFIMMUNEX CORP·Filed 1998·Granted Sep 19, 2000·20 cites·23 claims
- 2565US2018344855A1Stable Anti-inflammatory Solutions for InjectionOMEROS CORP·Filed 2018·Application pending·0 cites
- 2664US10047165B2Compositions for inhibiting MASP-2 dependent complement activationOMEROS CORP·Filed 2016·Granted Aug 14, 2018·0 cites·9 claims
- 2763US2017051039A1Compositions comprising a p75 tumor necrosis factor receptor/ig fusion proteinIMMUNEX CORP·Filed 2016·Application pending·0 cites
- 2863US2013035362A1Stable Anti-inflammatory Solutions for InjectionOMEROS CORP·Filed 2012·Application pending·0 cites
- 2959US2016166696A1Stable Anti-inflammatory Solutions for InjectionOMEROS CORP·Filed 2015·Application pending·0 cites
- 3056US2003180287A1Polypeptide formulationIMMUNEX CORP·Filed 2003·Application pending·0 cites
- 3154US9655981B2Mixed micellesOMEROS CORP·Filed 2016·Granted May 23, 2017·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →